bluebird bio
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch bluebird bio and buy or sell other stocks, ETFs, and their options commission-free!About BLUE
bluebird bio, Inc. is a clinical-stage biotechnology company, which engages in researching, developing and commercializing potentially transformative gene therapies for severe genetic diseases. It also offers ZYNTEGLO or beti-cel and SKYSONA or eli-cel gene therapies.
CEODavid D. Meek
CEODavid D. Meek
Employees248
Employees248
HeadquartersSomerville, Massachusetts
HeadquartersSomerville, Massachusetts
Founded1992
Founded1992
Employees248
Employees248
BLUE Key Statistics
Market cap48.66M
Market cap48.66M
Price-Earnings ratio-0.24
Price-Earnings ratio-0.24
Dividend yield—
Dividend yield—
Average volume193.95K
Average volume193.95K
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$28.60
52 Week high$28.60
52 Week low$3.20
52 Week low$3.20
People also own
Based on the portfolios of people who own BLUE. This list is generated using Robinhood data, and it’s not a recommendation.